Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

vector pharma

vector pharma specialises in the provision of close strategic regulatory support to innovative small to medium-size development-phase pharma companies seeking product approval within the EU. vector pharma works very closely with clients on a limited number of projects. Before taking on a contract we will discuss your requirements in detail. If we consider that a project is not appropriate for our resources or expertise we will tell you so.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

- PMLiVE

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Company Details

vector pharma
2 Victoria Road, Harpenden, Hertfordshire, AL5 4EA, United Kingdom
+44 (0)1582 761266
Contact vector pharma
Website

 Latest Content from PMHub 

It takes two – Maximising the client-agency relationship

White Papers and Resources | April 19, 2022 | Dice Medical Communications

How to start, build and maintain a great client-agency relationship (Written 3rd March 2021)

Top 10 Tips for “Virtualizing” In-person Meetings

Videos and Podcasts | April 14, 2022 | Impetus Digital

While Pharma was already slowly pivoting towards virtual events as a substitute for, or supplement to, in-person meetings, COVID-19 quickly changed virtual events from a nice-to-have to a must. With...

Virtualizing Healthcare with Human-Centric Technology

Videos and Podcasts | April 14, 2022 | Impetus Digital

Dr. Patrick Carroll, Chief Medical Officer at Vida Health, discusses the importance of using a “whole health” approach to chronic disease management, how and why the human connection with a...

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Press Releases | April 14, 2022 | Onyx Health

Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solutions.

From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting

Press Releases | April 14, 2022 | Nucleus Global

Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting

Importance of Diversity in Pharma and Clinical Trials

White Papers and Resources | April 13, 2022 | Impetus Digital

No matter which sector you work in, diversity and inclusion are must-haves!

Launch excellence

Press Releases | April 12, 2022 | Lucid Group Communications Limited

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events

White Papers and Resources | April 11, 2022 | Impetus Digital

In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees....

Meet The Lucid Group Talent Team

Videos and Podcasts | April 11, 2022 | Lucid Group Communications Limited

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Celebrating the new UK rare diseases framework

White Papers and Resources | April 8, 2022 | Dice Medical Communications

Dice's take on the importance of the rare diseases framework